The burden of diabetic cardiovascular autonomic neuropathy (CAN) is expected to increase
due to the diabetes epidemic and its early and widespread appearance. CAN has a definite …

A growing body of evidence points to the role of glucose variability (GV) in the development
of the microvascular and macrovascular complications of diabetes. In this review, we …

There may be significant deficiencies in the knowledge among nurses, 38–40 an issue
recognised by many. 41 A survey of community nurses in Ireland found that more than half …

Cardiac autonomic neuropathy (CAN) is a major complication of type 1 and type 2 diabetes
mellitus (T1DM and T2DM). The increased morbidity, cardiovascular and all-cause mortality …

Diabetic neuropathy (DN) encompasses a group of clinical or subclinical manifestations
involving a dysfunction in the peripheral nervous system. The cause of the dysfunction is the …

Background Some studies have suggested that patients with diabetes and foot
complications have worse cardiovascular and cerebrovascular risk profiles, higher degrees …

A prediabetic state is a major risk factor for the development of diabetes, and, because of an
identical pathophysiological background of both conditions, their prevalence increases …

Assessment of the cardiovascular parameters using noncontact video-based or imaging
photoplethysmography (IPPG) is usually considered as inaccurate because of strong …

Purpose The present study aimed to examine association between inflammatory and
endothelial function biomarkers and indices of cardiac autonomic control in T2DM patients …

Background It is presently unclear whether glycemic variability (GV) is associated with
baroreflex sensitivity (BRS), which is an early indicator of cardiovascular autonomic …